Targeted lipidomics: Discovery of new fatty acyl amides

AAPS Journal

Volumn 8, Issue 3, 2006, Pages

  Tan, Bo ^a   Bradshaw, Heather B ^a   Rimmerman, Neta ^a   Srinivasan, Harini ^a   Yu, Y William ^a   Krey, Jocelyn F ^a   Monn, M Francesca ^a   Chen, J Shih Chieh ^a   Hu, Sherry Shu Jung ^a   Pickens, Sarah R ^a   Walker, J Michael ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Cannabinoid; Fatty acyl amide; HPLC MS MS; Information dependent acquisition; Lipidomics; Nano HPLC

Indexed keywords

AMIDE; ANANDAMIDE; FATTY ACID DERIVATIVE; FATTY ACYL AMIDE DERIVATIVE; N ARACHIDONOYLDOPAMINE; N OLEOYLETHANOLAMINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; AUTOMATION; CARBON NUCLEAR MAGNETIC RESONANCE; CENTRAL NERVOUS SYSTEM FUNCTION; COLUMN CHROMATOGRAPHY; DATA BASE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFORMATION RETRIEVAL; LIPID ANALYSIS; LIPOGENESIS; NONHUMAN; PERIPHERAL NERVOUS SYSTEM FUNCTION; PROCESS OPTIMIZATION; PURIFICATION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; TIME OF FLIGHT MASS SPECTROMETRY;

AMIDES; ARACHIDONIC ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FATTY ACIDS; LIPID METABOLISM; LIPIDS; POLYUNSATURATED ALKAMIDES; SIGNAL TRANSDUCTION;

EID: 33746401106     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/aapsj080354     Document Type: Article

References (31)

1. Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258:1946-1949.
2. Mechoulam R, Ben-Shabat S, Hanus L, et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol. 1995;50:83-90.
3. Huang SM, Bisogno T, Trevisani M, et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA. 2002;99:8400-8405.
4. Huang SM, Bisogno T, Petros TJ, et al. Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem. 2001;276:42639-42644.
5. Bradshaw HB, Walker JM. The expanding field of cannabimimetic and related lipid mediators. Br J Pharmacol. 2005;144:459-465.
6. Elphick MR, Egertova M. The neurobiology and evolution of cannabinoid signalling. Philos Trans R Soc Lond B Biol Sci. 2001;356:381-408.
7. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci. 2003;4:873-884.
8. Mackie K. Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol. 2006;46:101-122.
9. Walker JM, Huang SM. Cannabinoid analgesia. Pharmacol Ther. 2002;95:127-135.
10. Bradshaw HB, Rimmerman N, Krey JF, Walker JM. Sex and hormonal cycle differences in brain levels of pain-related cannabimimetic lipid mediators. Am J Physiol Regul Integr Comp Physiol [serial online]. 2006;Mar:.
11. Croxford JL, Yamamura T. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? J Neuroimmunol. 2005;166:3-18.
12. Ralevic V, Kendall DA, Randall MD, Smart D. Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function. Life Sci. 2002;71:2577-2594.
13. Crawley JN, Corwin RL, Robinson JK, Felder CC, Devane WA, Axelrod J. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol Biochem Behav. 1993;46:967-972.
14. Ross RA. Anandamide and vanilloid TRPV1 receptors. Br J Pharmacol. 2003;140:790-801.
15. Hanus L, Gopher A, Almog S, Mechoulam R. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. J Med Chem. 1993;36:3032-3034.
16. Kuehl FA, Jr, Jacob TA, Ganley OH, Ormond RE, Meisinger MAP. The identification of N-2 (hydroxyethyl)-palmitamide as a naturally occurring anti-inflammatory agent. J Am Chem Soc. 1957;79:5577-5578.
17. Bachur NR, Masek K, Melmon KL, Udenfriend S. Fatty acid amides of ethanolamine in mammalian tissues. J Biol Chem. 1965;240:1019-1024.
18. Calignano A, La Rana G, Giuffrida A, Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature. 1998;394:277-281.
19. Fontana A, Di Marzo V, Cadas H, Piomelli D. Analysis of anandamide, an endogenous cannabinoid substance, and of other natural N-acylethanolamines. Prostaglandins Leukot Essent Fatty Acids. 1995;53:301-308.
20. Fu J, Gaetani S, Oveisi F, et al. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature. 2003;425:90-93.
21. Guzman M, Lo Verme J, Fu J, Oveisi F, Blazquez C, Piomelli D. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). J Biol Chem. 2004;279:27849-27854.
22. Ahern GP. Activation of TRPV1 by the satiety factor oleoylethanolamide. J Biol Chem. 2003;278:30429-30434.
23. Chu CJ, Huang SM, De Petrocellis L, et al. N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J Biol Chem. 2003;278:13633-13639.
24. De Petrocellis L, Chu CJ, Moriello AS, Kellner JC, Walker JM, Marzo VD. Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels. Br J Pharmacol. 2004;143:251-256.
25. Sheskin T, Hanus L, Slager J, Vogel Z, Mechoulam R. Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J Med Chem. 1997;40:659-667.
26. Milman G, Maor Y, Abu-Lafi. S, et al. N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties. Proc Natl Acad Sci USA. 2006;103:2428-2433.
27. Hansen HS, Lauritzen L, Moesgaard B, Strand AM, Hansen HH. Formation of N-acyl-phosphatidylethanolamines and N-acetylethanolamines: proposed role in neurotoxicity. Biochem Pharmacol. 1998;55:719-725.
28. Josephs JL. Detection and characterization of fumonisin mycotoxins by liquid chromatography/electrospray ionization using ion trap and triple quadrupole mass spectrometry. Rapid Commun Mass Spectrom. 1996;10:1333-1344.
29. Scholz K, Dekant W, Volkel W, Pahler A. Rapid detection and identification of N-acetyl-L-cysteine thioethers using constant neutral loss and theoretical multiple reaction monitoring combined with enhanced product-ion scans on a linear ion trap mass spectrometer. J Am Soc Mass Spectrom. 2005;16:1976-1984.
30. Schwudke D, Oegema J, Burton L, et al. Lipid profiling by multiple precursor and neutral loss scanning driven by the data-dependent acquisition. Anal Chem. 2006;78:585-595.
31. Saghatelian A, Trauger SA, Want EJ, Hawkins EG, Siuzdak G, Cravatt BF. Assignment of endogenous substrates to enzymes by global metabolite profiling. Biochemistry. 2004;43:14332-14339.